Literature DB >> 18086567

Glucose-6-phosphate dehydrogenase Buenos Aires: a novel de novo missense mutation associated with severe enzyme deficiency.

Angelo Minucci1, Paola Concolino, Francesca Vendittelli, Bruno Giardina, Cecilia Zuppi, Ettore Capoluongo.   

Abstract

OBJECTIVE: : Glucose 6-phosphate dehydrogenase (G6PD) catalyzes the first committed steps in the pentose phosphate pathway: the generation of NADPH by this enzyme is essential for protection against oxidative stress. The human enzyme is in a dimer<-->tetramer equilibrium and its stability depends on NADP(+) concentration. Herein, we report a case of a symptomatic baby affected by severe deficiency of G6PD activity due to a novel de novo genetic mutation (g1465C>T) in the thirteenth exon of its gene.
METHODS: : Clinical, biochemical and genetic evaluations of the affected baby and his mother were performed.
RESULTS: : We found the g1465C>T novel mutation, in the thirteenth exon of G6PD gene (named "G6PD Buenos Aires variant"). This g1465C>T mutation produce a P489S substitution at protein level. The P489S mutation was absent in his mother, suggesting that G6PD Buenos Aires resulted from a de novo mutation.
CONCLUSIONS: : The absence of mosaicism in the baby's DNA (from saliva and blood samples) suggests that a de novo mutation event may occur in the very early stages in embryogenesis or in the mother's germ cell lines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086567     DOI: 10.1016/j.clinbiochem.2007.11.009

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

Review 1.  Dosage Compensation in Females with X-Linked Metabolic Disorders.

Authors:  Patrycja Juchniewicz; Ewa Piotrowska; Anna Kloska; Magdalena Podlacha; Jagoda Mantej; Grzegorz Węgrzyn; Stefan Tukaj; Joanna Jakóbkiewicz-Banecka
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

2.  A novel point mutation in a class IV glucose-6-phosphate dehydrogenase variant (G6PD São Paulo) and polymorphic G6PD variants in São Paulo State, Brazil.

Authors:  Raimundo Antonio G Oliveira; Marilena Oshiro; Mario H Hirata; Rosario D C Hirata; Georgina S Ribeiro; Tereza M D Medeiros; Orlando C de O Barretto
Journal:  Genet Mol Biol       Date:  2009-06-01       Impact factor: 1.771

3.  The first reported case of G6PD deficiency due to Seoul mutation in Poland.

Authors:  Barbara Kaczorowska-Hac; Beata Burzynska; Danuta Plochocka; Katarzyna Zak-Jasinska; Katarzyna Rawa; Elzbieta Adamkiewicz-Drozynska
Journal:  Ann Hematol       Date:  2014-05       Impact factor: 3.673

Review 4.  G6PD deficiency in Latin America: systematic review on prevalence and variants.

Authors:  Wuelton M Monteiro; Fernando F A Val; André M Siqueira; Gabriel P Franca; Vanderson S Sampaio; Gisely C Melo; Anne C G Almeida; Marcelo A M Brito; Henry M Peixoto; Douglas Fuller; Quique Bassat; Gustavo A S Romero; Oliveira Maria Regina F; Lacerda Marcus Vinícius G
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08-19       Impact factor: 2.743

5.  Detection of Occult Acute Kidney Injury in Glucose-6-Phosphate Dehydrogenase Deficiency Anemia.

Authors:  Gehan Lotfy Abdel Hakeem; Emad Allam Abdel Naeem; Salwa Hussein Swelam; Laila El Morsi Aboul Fotoh; Abdel Azeem Mohamed El Mazary; Ashraf Mohamed Abdel Fadil; Asmaa Hosny Abdel Hafez
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-08-20       Impact factor: 2.576

6.  Five novel glucose-6-phosphate dehydrogenase deficiency haplotypes correlating with disease severity.

Authors:  Ashraf Dallol; Huda Banni; Mamdooh A Gari; Mohammed H Al-Qahtani; Adel M Abuzenadeh; Fatin Al-Sayes; Adeel G Chaudhary; Jeffrey Bidwell; Wael Kafienah
Journal:  J Transl Med       Date:  2012-09-24       Impact factor: 5.531

7.  Report of an Italian family carrying a typical Indian variant of the Nilgiris tribal groups resulting from a de novo occurrence.

Authors:  Giulia Canu; Giorgia Mazzuccato; Andrea Urbani; Angelo Minucci
Journal:  Hum Genome Var       Date:  2018-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.